Ca2+-inhibitable adenylyl cyclase and pulmonary microvascular permeability

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 273, Issue 1 17-1, 1997, Pages

  Chetham, Paul M ^a   Guldemeester, H Alexandra ^c   Mons, Nicole ^b   Brough, George H ^d   Bridges, James P ^a   Thompson, W Joseph ^d   Stevens, Troy ^d,e  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Adenosine 3',5' cyclic monophosphate; Calcium ion influx; Capillary filtration coefficient; Cytosolic calcium ion; Thapsigargin

Indexed keywords

ADENYLATE CYCLASE; CALCIUM ION; CYCLIC AMP;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; INFLAMMATION; LUNG BLOOD VESSEL; LUNG CIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030807958     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1997.273.1.l22     Document Type: Article

References (50)

1. Adkins, W., J. Barnard, S. May, A. Seibert, J. Haynes, and A. Taylor. Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury. J. Appl. Physiol. 72: 492-497, 1992.
2. Baluk, P., and D. McDonald. The β2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L461-L468, 1994.
3. Buchan, K., and W. Martin. Modulation of barrier function of bovine aortic and pulmonary artery endothelial cells: dissociation from cytosolic calcium content. Br. J. Pharmacol. 107: 932-938, 1992.
4. Bundgaard, M. The three-dimensional organization of tight junctions in a capillary endothelium revealed by serial-section electron microscopy. J. Ultrastruct. Res. 88: 1-17, 1984.
5. Casnocha, S., S. Eskin, E. Hall, and L. McIntire. Permeability of human endothelial monolayers: effect of vasoactive agonists and cAMP. J. Appl. Physiol. 67: 1997-2005, 1989.
6. 2+ inhibitable adenylyl cyclase in non-excitable cells. J. Biol. Chem. 270: 1149-1155, 1995.
7. Choi, E., Z. Xia, and D. Storm. Stimulation of type III olfactory adenylyl cyclase by calcium and calmodulin. Biochemistry 31: 6492-6498, 1992.
8. 2+-sensitive adenylyl cyclases. Biochem. J. 297: 437-440, 1994.
9. Crapo, J. New concepts in the formation of pulmonary edema. Am. Rev. Respir. Dis. 147: 790-792, 1993.
10. Demling, R. The modern version of adult respiratory distress syndrome. Annu. Rev. Med. 46: 193-202, 1995.
11. Diwan, H., W. Thompson, A. Lee, and S. Strada. Cyclic GMP-dependent protein kinase activity in rat pulmonary microvascular endothelial cells. Biochem. Biophys. Res. Commun. 202: 728-735, 1994.
12. Drake, R., K. Gaar, and A. Taylor. Estimation of the nitration coefficient of pulmonary exchange vessels. Am. J. Physiol. 234 (Heart Circ. Physiol. 3): H266-H274, 1978.
13. 2+ entry sites. J. Biol. Chem. 271: 12438-12444, 1996.
14. Farrukh, I., G. Gurtner, and J. Michael. Pharmacological modification of pulmonary vascular injury: possible role of cAMP. J. Appl. Physiol. 62: 47-54, 1987.
15. Garcia, J., H. Davis, and C. Patterson. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J. Cell. Physiol. 163: 510-522, 1995.
16. Garcia, J., and K. Schaphorst. Regulation of endothelial cell gap formation and paracellular permeability. J. Investig. Med. 43: 117-126, 1995.
17. Ghitescu, L., A. Fixman, M. Simionescu, and N. Simionescu. Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis. J. Cell Biol. 102: 1304-1311, 1986.
18. Goeckeler, Z., and R. Wysolmerski. Myosin light chain kinase-regulated endothelial cell contraction: The relationship between isometric tension, actin polymerization, and myosin phosphorylation. J. Cell Biol. 130: 613-627, 1995.
19. i and permeability in microvessels exposed to ATP. Am. J. Physiol. 34 (Heart Circ. Physiol. 33): H1019-H1023, 1993.
20. Langeler, E., and V. Hinsbergh. Norepinephrine and iloprost improve barrier function of human endothelial cell monolayers: role of cAMP. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1798-H1809, 1993.
21. Laposata, M., D. Dovnarsky, and H. Shin. Thrombin-induced gap formation in confluent endothelial cell monolayers in vitro. Blood 62: 549-556, 1983.
22. Lum, H., and A. Malik. Regulation of vascular endothelial barrier function. Am. J. Physiol. 267 (Lung Cell. Mol. Physiol. 30): L223-L241, 1994.
23. Manolopoulos, V., J. Liu, B. Unsworth, and P. Lelkes. Diversity of adenylate cyclase isoforms expressed in endothelial cells from various rat tissues (Abstract). FASEB J. 8: A38, 1994.
24. Minnear, F., A. Johnson, and A. Malik. β-Adrenergic modulation of pulmonary transvascular fluid and protein exchange. J. Appl. Physiol. 60: 266-274, 1986.
25. Mons, N., A. Harry, P. Dubourg, R. Premont, R. Iyengar, and D. Cooper. Immunohistochemical localization of adenylyl cyclase in rat brain indicates a highly selective concentrations at synapses. Proc. Natl. Acad. Sci. USA 92: 8473-8477, 1995.
26. Moy, A., S. Shasby, B. Scott, and D. Shasby. The effect of histamine and cyclic adenosine monophosphate on myosin light chain phosphorylation in human umbilical vein endothelial cells. J. Clin. Invest. 92: 1198-1206, 1993.
27. Moy, A., J. Ven Engelenhoven, J. Bodmer, J. Kamath, C. Keese, I. Giaever, S. Shasby, and D. Shasby. Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces. J. Clin. Invest. 97: 1020-1027, 1996.
28. Nicolaysen, G. Increase in capillary filtration rate resulting from reduction in the intravascular calcium ion-concentration. Acta Physiol. Scand. 81: 517-527, 1971.
29. Patterson, C., H. Davis, K. Schaphorst, and J. Garcia. Mechanisms of cholera toxin prevention of thrombin- and PMA-induced endothelial cell barrier dysfunction. Microvasc. Res. 48: 212-235, 1994.
30. Patterson, C., J. Stasek, K. Schaphorst, H. Davis, and J. Garcia. Mechanisms of pertussis toxin-induced barrier dysfunction in bovine pulmonary artery endothelial cell monolayers. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L926-L934, 1995.
31. Premont, R., J. Chen, H.-W. Ma, M. Ponnapalli, and R. Iyengar. Two members of a widely expressed subfamily of hormone-stimulated adenylyl cyclases. Proc. Natl. Acad. Sci. USA 89: 9809-9813, 1992.
32. Schnittler, H., A. Wilke, T. Gress, N. Suttorp, and D. Drenckhan. Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endothelium. J. Physiol. (Lond.) 431: 379-401, 1990.
33. Schnitzer, J., A. Siflinger-Birnboim, P. Del Vecchio, and A. Malik. Segmental differentiation of permeability, protein glycosylation, and morphology of cultured bovine lung vascular endothelium. Biochem. Biophys. Res. Commun. 199: 11-19, 1994.
34. Shasby, D., and S. Shasby. Effects of calcium on transendothelial albumin transfer and electrical resistance. J. Appl. Physiol. 60: 71-79, 1986.
35. Shasby, D., S. Shasby, J. Sullivan, and M. Peach. Role of endothelial cell cytoskeleton in control of endothelial permeability. Circ. Res. 51: 657-661, 1982.
36. Sheldon, R., A. Moy, K. Lindsley, S. Shasby, and D. Shasby. Role of myosin light-chain phosphorylation in endothelial cell retraction. Am. J. Physiol. 265 (Lung Cell. Mol. Physiol. 9): L606-L612, 1993.
37. Siebert, A., J. Haynes, and A. Taylor. Ischemia-reperfusion injury in the isolated rat lung. Role of flow and endogenous leukocytes. Am. Rev. Respir. Dis. 147: 270-275, 1993.
38. Siflinger-Birnboim, A., D. Bode, and A. Malik. Adenosine 3′,5′-cyclic monophosphate attenuates neutrophil-mediated increase in endothelial permeability. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H370-H375, 1993.
39. Simionescu, N., M. Simionescu, and G. Palade. Structural basis of permeability in sequential segments of the microvasculature of the diaphragm. II. Pathways followed by microperoxidase across the endothelium. Microvasc. Res. 15: 17-36, 1978.
40. Stelzner, T., J. Weil, and R. O'Brien. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J. Cell. Physiol. 139: 157-166, 1989.
41. 2+ and adenylyl cyclase responses in phenotypically distinct pulmonary endothelial cells. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L51-L59, 1997.
42. Stevens, T., Y. Nakahashi, D. Cornfield, I. McMurtry, D. Cooper, and D. Rodman. Calcium inhibitable adenylyl cyclase modulates pulmonary artery endothelial cell cAMP content and barrier function. Proc. Natl. Acad. Sci. USA 92: 2696-2700, 1995.
43. Suttorp, N., U. Weber, T. Welsch, and C. Schudt. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J. Clin. Invest. 91: 1421-1428, 1993.
44. Taylor, A., and K. Garr. Estimation of equivalent pore radii of pulmonary capillary and alveolar membranes. Am. J. Physiol. 218: 1133-1140, 1970.
45. 2+ ATPase. Proc. Natl. Acad. Sci. USA 87: 2466-2470, 1990.
46. 2+ oscillations in HEK-293 cells. J. Biol. Chem. 270: 24108-24115, 1995.
47. 2+ inhibition of type III adenylyl cyclase in vivo. J. Biol. Chem. 270: 21480-21486, 1995.
48. Wei, J., G. Wayman, and D. Storm. Phosphorylation and inhibition of type III adenylyl cyclase by calmodulin-dependent protein kinase II in vivo. J. Biol. Chem. 271: 24231-24235, 1996.
49. Wysolmerski, R., and D. Lagunoff. Involvement of myosin light-chain kinase in endothelial cell retraction. Proc. Natl. Acad. Sci. USA 87: 16-20, 1990.
50. Wysolmerski, R., and D. Lagunoff. Regulation of permeabilized endothelial cell retraction by myosin phosphorylation. Am. J. Physiol. 261 (Cell Physiol. 30): C32-C40, 1991.